Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors

Mr. Pasternak brings decades of global pharmaceutical leadership experience

Transition further highlights transformation of the Board to lead Context into next phase of growth

Read more at globenewswire.com